ACP

Acuta Capital Partners Portfolio holdings

AUM $71.6M
This Quarter Return
+23.75%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$281M
AUM Growth
+$281M
Cap. Flow
+$20.8M
Cap. Flow %
7.4%
Top 10 Hldgs %
60.27%
Holding
52
New
15
Increased
6
Reduced
10
Closed
6

Top Buys

1
WHWK
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$44.9M
2
BLU
BELLUS Health Inc.
BLU
$12.3M
3
IOVA icon
Iovance Biotherapeutics
IOVA
$5.55M
4
GHRS icon
GH Research
GHRS
$5.37M
5
OLMA icon
Olema Pharmaceuticals
OLMA
$4.15M

Top Sells

1
CLDX icon
Celldex Therapeutics
CLDX
$35.1M
2
FULC icon
Fulcrum Therapeutics
FULC
$7.94M
3
EPIX icon
ESSA Pharma
EPIX
$6.65M
4
ALGS icon
Aligos Therapeutics
ALGS
$4.37M
5
AVDL
Avadel Pharmaceuticals
AVDL
$3.78M

Sector Composition

1 Healthcare 94.48%
2 Financials 4.94%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ATHA icon
26
Athira Pharma
ATHA
$15.5M
$2.79M 0.98%
297,362
-129,698
-30% -$1.22M
RAIN
27
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$2.73M 0.96%
182,500
+20,255
+12% +$303K
GOSS icon
28
Gossamer Bio
GOSS
$587M
$2.7M 0.95%
+215,000
New +$2.7M
MRUS icon
29
Merus
MRUS
$5.04B
$2.68M 0.95%
+122,000
New +$2.68M
ACRS icon
30
Aclaris Therapeutics
ACRS
$223M
$2.54M 0.89%
140,839
-34,161
-20% -$615K
APLS icon
31
Apellis Pharmaceuticals
APLS
$3.51B
$2.49M 0.88%
75,500
-85,000
-53% -$2.8M
VRDN icon
32
Viridian Therapeutics
VRDN
$1.59B
$2.23M 0.79%
+135,807
New +$2.23M
ALLK
33
DELISTED
Allakos
ALLK
$1.85M 0.65%
+17,500
New +$1.85M
RETA
34
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$1.76M 0.62%
17,500
+7,500
+75% +$755K
ALT icon
35
Altimmune
ALT
$325M
$1.7M 0.6%
+150,000
New +$1.7M
BCYC
36
Bicycle Therapeutics
BCYC
$492M
$1.59M 0.56%
+38,184
New +$1.59M
GYRE icon
37
Gyre Therapeutics
GYRE
$734M
$1.5M 0.53%
365,000
-320,000
-47% -$1.32M
RNA icon
38
Avidity Biosciences
RNA
$6.12B
$1.48M 0.52%
60,000
– –
CMRX
39
DELISTED
Chimerix, Inc.
CMRX
$1.3M 0.46%
210,000
-299,164
-59% -$1.85M
CBAY
40
DELISTED
Cymabay Therapeutics
CBAY
$1.1M 0.39%
301,904
– –
CCCC icon
41
C4 Therapeutics
CCCC
$182M
$938K 0.33%
+21,000
New +$938K
ELAN icon
42
Elanco Animal Health
ELAN
$8.62B
$925K 0.33%
+29,000
New +$925K
UTHR icon
43
United Therapeutics
UTHR
$17.7B
$554K 0.2%
+3,000
New +$554K
NVAX icon
44
Novavax
NVAX
$1.2B
$480K 0.17%
2,315
– –
NUVB.WS icon
45
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$63.9M
$242K 0.09%
90,832
– –
EPIX icon
46
ESSA Pharma
EPIX
$11.2M
– –
-232,896
Closed -$6.65M
CPRX icon
47
Catalyst Pharmaceutical
CPRX
$2.42B
– –
-329,134
Closed -$1.89M
AVDL
48
Avadel Pharmaceuticals
AVDL
$1.42B
– –
-561,011
Closed -$3.78M
ATXS icon
49
Astria Therapeutics
ATXS
$394M
– –
-1,173,674
Closed -$2.48M
ALGS icon
50
Aligos Therapeutics
ALGS
$75.1M
– –
-214,254
Closed -$4.37M
1
2
3